GB9310635D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9310635D0
GB9310635D0 GB939310635A GB9310635A GB9310635D0 GB 9310635 D0 GB9310635 D0 GB 9310635D0 GB 939310635 A GB939310635 A GB 939310635A GB 9310635 A GB9310635 A GB 9310635A GB 9310635 D0 GB9310635 D0 GB 9310635D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939310635A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB939310635A priority Critical patent/GB9310635D0/en
Publication of GB9310635D0 publication Critical patent/GB9310635D0/en
Priority to ZA943494A priority patent/ZA943494B/xx
Priority to TW083104441A priority patent/TW279866B/zh
Priority to EP94917647A priority patent/EP0699196A1/en
Priority to PCT/EP1994/001613 priority patent/WO1994027989A1/en
Priority to CZ953051A priority patent/CZ305195A3/cs
Priority to HU9503321A priority patent/HUT73790A/hu
Priority to CN94192683A priority patent/CN1126473A/zh
Priority to CA002162921A priority patent/CA2162921A1/en
Priority to AU69287/94A priority patent/AU6928794A/en
Priority to PL94311702A priority patent/PL311702A1/xx
Priority to SK1424-95A priority patent/SK142495A3/sk
Priority to JP7500181A priority patent/JPH08510455A/ja
Priority to IL10970394A priority patent/IL109703A0/xx
Priority to PE1994255110A priority patent/PE31195A1/es
Priority to OA60742A priority patent/OA10195A/en
Priority to FI955587A priority patent/FI955587A7/fi
Priority to NO954681A priority patent/NO954681L/no
Priority to BG100154A priority patent/BG100154A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB939310635A 1993-05-21 1993-05-21 Chemical compounds Pending GB9310635D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
ZA943494A ZA943494B (en) 1993-05-21 1994-05-02 Chemical compounds
TW083104441A TW279866B (enExample) 1993-05-21 1994-05-17
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
CA002162921A CA2162921A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17, 20-lyase-inhibiting activity
JP7500181A JPH08510455A (ja) 1993-05-21 1994-05-19 １７，２０―リアーゼ阻害活性を有するカルバゾール誘導体
CZ953051A CZ305195A3 (en) 1993-05-21 1994-05-19 Carbazole derivatives, process of their preparation, their use and pharmaceutical compositions containing thereof
HU9503321A HUT73790A (en) 1993-05-21 1994-05-19 Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them
CN94192683A CN1126473A (zh) 1993-05-21 1994-05-19 化学组合物
EP94917647A EP0699196A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
AU69287/94A AU6928794A (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
PL94311702A PL311702A1 (en) 1993-05-21 1994-05-19 Chemical compounds
SK1424-95A SK142495A3 (en) 1993-05-21 1994-05-19 Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use
IL10970394A IL109703A0 (en) 1993-05-21 1994-05-20 Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them
PE1994255110A PE31195A1 (es) 1993-05-21 1994-11-18 Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene
OA60742A OA10195A (en) 1993-05-21 1995-11-17 Carbazole derivatives with 17 20-lyase-inhibiting activity
FI955587A FI955587A7 (fi) 1993-05-21 1995-11-20 Kemialliset yhdisteet
NO954681A NO954681L (no) 1993-05-21 1995-11-20 Kjemiske forbindelser
BG100154A BG100154A (en) 1993-05-21 1995-11-21 Carbazole derivatibes having inhibiting effect to 17,20-lyase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9310635D0 true GB9310635D0 (en) 1993-07-07

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939310635A Pending GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds

Country Status (19)

Country Link
EP (1) EP0699196A1 (enExample)
JP (1) JPH08510455A (enExample)
CN (1) CN1126473A (enExample)
AU (1) AU6928794A (enExample)
BG (1) BG100154A (enExample)
CA (1) CA2162921A1 (enExample)
CZ (1) CZ305195A3 (enExample)
FI (1) FI955587A7 (enExample)
GB (1) GB9310635D0 (enExample)
HU (1) HUT73790A (enExample)
IL (1) IL109703A0 (enExample)
NO (1) NO954681L (enExample)
OA (1) OA10195A (enExample)
PE (1) PE31195A1 (enExample)
PL (1) PL311702A1 (enExample)
SK (1) SK142495A3 (enExample)
TW (1) TW279866B (enExample)
WO (1) WO1994027989A1 (enExample)
ZA (1) ZA943494B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721943A4 (en) * 1993-09-30 1996-09-04 Yamanouchi Pharma Co Ltd AZOL DERIVATIVES AND PHARMACEUTICAL PREPARATIONS
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
NZ302392A (en) * 1995-03-01 1998-08-26 Yamanouchi Pharma Co Ltd Tricyclic substituted imidazole derivatives and medicaments thereof
CN1251577A (zh) * 1997-02-21 2000-04-26 武田药品工业株式会社 稠环化合物及其生产和应用
CA2429133C (en) 2000-11-17 2009-08-18 Takeda Chemical Industries, Ltd. Novel imidazole derivatives, production method thereof and use thereof
DE60144246D1 (de) 2000-11-20 2011-04-28 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
AU2006262283B2 (en) * 2005-06-24 2011-10-13 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators (SARM)
GB0525323D0 (en) 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
PE20121048A1 (es) 2009-06-26 2012-08-25 Novartis Ag Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
JP5964756B2 (ja) * 2010-02-04 2016-08-03 ラジウス ヘルス，インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
PL2568806T3 (pl) 2010-05-12 2017-03-31 Radius Health, Inc. Schematy lecznicze
KR101594660B1 (ko) 2010-08-04 2016-02-16 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
AU2011312490B2 (en) 2010-09-28 2015-06-25 Radius Pharmaceuticals, Inc. Selective androgen receptor modulators
MX359399B (es) 2011-04-28 2018-09-27 Novartis Ag Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
ES2939940T3 (es) 2014-03-28 2023-04-28 Univ Duke Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
WO2016040896A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
WO2017223115A1 (en) 2016-06-22 2017-12-28 Radius Health, Inc. Ar+ breast cancer treatment methods
WO2018080933A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
NO954681D0 (no) 1995-11-20
PE31195A1 (es) 1995-10-18
FI955587A0 (fi) 1995-11-20
IL109703A0 (en) 1994-08-26
WO1994027989A1 (en) 1994-12-08
NO954681L (no) 1995-11-20
CZ305195A3 (en) 1996-06-12
OA10195A (en) 1996-12-18
AU6928794A (en) 1994-12-20
HUT73790A (en) 1996-09-30
PL311702A1 (en) 1996-03-04
CA2162921A1 (en) 1994-12-08
JPH08510455A (ja) 1996-11-05
TW279866B (enExample) 1996-07-01
ZA943494B (en) 1995-01-23
FI955587A7 (fi) 1995-11-20
EP0699196A1 (en) 1996-03-06
BG100154A (en) 1996-07-31
SK142495A3 (en) 1996-06-05
CN1126473A (zh) 1996-07-10
HU9503321D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
GB9304618D0 (en) Chemical compounds
GB9301000D0 (en) Chemical compounds
GB9312210D0 (en) Chemical compounds
GB9305468D0 (en) Chemical compounds
ZA943494B (en) Chemical compounds
GB9305469D0 (en) Chemical compounds
GB2280677B (en) Chemical compounds
GB9305509D0 (en) Chemical compounds
GB9307749D0 (en) Chemical compounds
GB9305510D0 (en) Chemical compounds
GB9305459D0 (en) Chemical compounds
GB9305806D0 (en) Chemical compounds
GB9314977D0 (en) Chemical compounds
GB9306941D0 (en) Chemical compounds
GB9304641D0 (en) Chemical compounds
GB9307339D0 (en) Chemical compounds
GB9304640D0 (en) Chemical compounds
GB9314978D0 (en) Chemical compounds
GB9304642D0 (en) Chemical compounds
GB9310560D0 (en) Chemical compounds
GB9310565D0 (en) Chemical compounds
GB9314975D0 (en) Chemical compounds
GB9300557D0 (en) Chemical compounds
GB9303987D0 (en) Chemical compounds
GB9310884D0 (en) Chemical compounds